Cite

HARVARD Citation

    Mulder, T. et al. (2021). Ibrutinib Has Time-dependent On- and Off-target Effects on Plasma Biomarkers and Immune Cells in Chronic Lymphocytic Leukemia. HemaSphere. 5 (5), pp. e564-. [Online]. 
  
Back to record